Catalyst Wire Dossier Catalyst Wire Dossier

Nasapaque Nasal Solution

· 3E Therapeutics Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nasapaque Nasal Solution, covering 2017-01-26 to 2017-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis [Phase 1, Phase 2]

See pricing